Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Core Insights - Seer, Inc. will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, highlighting its role in the healthcare sector [1] - The management will engage in a fireside chat on September 9, 2025, providing an opportunity for investors to gain insights into the company's operations [2] Company Overview - Seer, Inc. is a leader in deep, unbiased proteomics, offering insights with unprecedented scale, speed, precision, and reproducibility [3] - The Proteograph Product Suite integrates proprietary engineered nanoparticles, streamlined automation, optimized consumables, and advanced analytical software to address challenges faced by traditional proteomic methods [3] - Seer's technology overcomes limitations of conventional proteomics, such as inconsistent data and limited throughput, enabling the discovery of biological insights [3]